Ogilvie′s syndrome following posterior spinal instrumentation in thoraco lumbar trauma

Krishnakumar, R.; Kuzhimattam, Mathew John; Gaurav, Kumar

doi:10.4103/0974-8237.167866

Cited by 10 publications

(5 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ACPO has been observed in 1-2% of spinal or othopaedic procedures. In the field of spinal surgery, Ogilvie syndrome was reported after posterior fixation for thoracolumbar fractures, lumbar disc, cervical discectomy, lumbar decompression for stenosis, correction of spinal deformity, and lumbar surgery (8,9,18,23,24,25).…”

Section: Discussionmentioning

confidence: 99%

“…ACPO has been described in hospitalized patients with severe illness, trauma, or after surgical procedures (cesarean, abdominal, pelvic ,urologic , thoracic, neurosurgical, coronary bypass, orthopaedic surgeries) (1, 2, 3, 5, 6). ACPO has also been described after some orthopedic procedures such as hip, knee, lumbar and cervical surgeries (8)(9)(10)(11)(12).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Ogilvie syndrome following spinal surgery

Pinheiro¹,

Nascimento²,

Costa³

et al. 2021

Sanamed

View full text Add to dashboard Cite

Objective: Ogilvie syndrome is a rare disease characterized by acute abdominal pain and distention in the absence of mechanical obstruction. It is a rare condition that usually affects hospitalized patients in association with severe illness or after surgery. A few cases have been reported after spinal surgery.Material and Methods: Retrospective reports of Ogilvie syndrome in three patients that underwent spinal surgery (two posterior lumbar instrumented fusion and one anterior cervical fusion). Surgical treatment was required in two patients and conservative treatment in one out the three patients.Results: Two patients had a complete recovery of symptoms and signs of the disease, and one died.Conclusion: Ogilvie syndrome is rare, but it should be considered a differential diagnosis in patients who have undergone surgery and present with significant abdominal pain and distention.Level of evidence II; Retrospective study.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Ogilvie syndrome following spinal surgery

Pinheiro¹,

Nascimento²,

Costa³

et al. 2021

Sanamed

View full text Add to dashboard Cite

show abstract

“…Ogilvie's syndrome (OS) is a rare disorder of unknown pathophysiology characterized by acute dilatation of the colon in the absence of an anatomic lesion that obstructs the flow of intestinal contents 9,10 . OS has also been observed after spine surgery, especially in the lumbar region 11–13 . In this manuscript, we report a single case of a patient who developed acute abdominal pain following SCS implantation and subsequently developed Ogilvie's syndrome with lethal outcome despite immediate spinal decompression.…”

Section: Introduction and Literature Summarymentioning

confidence: 98%

“…9,10 OS has also been observed after spine surgery, especially in the lumbar region. [11][12][13] In this manuscript, we report a single case of a patient who developed acute abdominal pain following SCS implantation and subsequently developed Ogilvie's syndrome with lethal outcome despite immediate spinal decompression. There is currently no Abstract Spinal cord stimulation (SCS) is an emerging technology to treat chronic pain from complex regional pain syndrome (CPRS) neuropathy and post-laminectomy syndrome.…”

Section: Introduction a N D Li T Er At U R E Su M M A Rymentioning

confidence: 98%

Ogilvie's syndrome after paddle spinal cord stimulator implantation: An experience report

Zemmar

Sinofsky²,

Sheng

et al. 2023

Pain Practice

View full text Add to dashboard Cite

Spinal cord stimulation (SCS) is an emerging technology to treat chronic pain from complex regional pain syndrome (CPRS) neuropathy and post‐laminectomy syndrome. A rarely reported postoperative complication of SCS paddle implantation is abdominal pain that can result from thoracic radiculopathy. Ogilvie's syndrome (OS) is a disorder characterized by acute dilatation of the colon in the absence of an anatomic lesion that obstructs the flow of intestinal contents, which has seldom been observed after spine surgery. Here, we describe the case of a 70‐year‐old male who developed OS after SCS paddle implantation resulting in cecal perforation and multi‐system organ failure with lethal outcome. We discuss the pathophysiology, present a method measuring the spinal canal to cord ratio (CCR) to prevent the risk of thoracic radiculopathy and OS after paddle SCS implantation, and propose suggestions for management and treatment of this condition.

show abstract

“…Increased drug resistance of bacteria is significantly reducing the therapeutic efficacy of antibiotics (Stewart and Costerton, 2001). Commonly, this resistance is augmented in bacterial biofilms, which can be described as bacterial communities adhering to abiotic or biotic surfaces and encased in a self-produced extracellular matrix (Chung and Toh, 2014;Hall and Mah, 2017).…”

Section: Introductionmentioning

confidence: 99%

Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds

et al. 2020

View full text Add to dashboard Cite

Microorganisms grown in biofilms are more resistant to antimicrobial treatment and immune system attacks compared to their planktonic forms. In fact, infections caused by biofilm-forming Staphylococcus aureus and Staphylococcus epidermidis are a large threat for public health, including patients with medical devices. The aim of the current manuscript was to test the effect of dalbavancin, a recently developed lipoglycopeptide antibiotic, alone or in combination with compounds contributing to bacterial cell disaggregation, on staphylococcal biofilm formation and elimination. We used realtime impedance measurements in microtiter plates to study biofilm growth dynamics of S. aureus and S. epidermidis strains, in the absence or presence of dalbavancin, linezolid, vancomycin, cloxacillin, and rifampicin. Further experiments were undertaken to check whether biofilm-detaching compounds such as N-acetylcysteine (NAC) and ficin could enhance dalbavancin efficiency. Real-time dose-response experiments showed that dalbavancin is a highly effective antimicrobial, preventing staphylococcal biofilm formation at low concentrations. Minimum biofilm inhibitory concentrations were up to 22 higher compared to standard E-test values. Dalbavancin was the only antimicrobial that could halt new biofilm formation on established biofilms compared to the other four antibiotics. The addition of NAC decreased dalbavancin efficacy while the combination of dalbavancin with ficin was more efficient than antibiotic alone in preventing growth once the biofilm was established. Results were confirmed by classical biofilm quantification methods such as crystal violet (CV) staining and viable colony counting. Thus, our data support the use of dalbavancin as a promising antimicrobial to treat biofilm-related infections. Our data also highlight that synergistic and antagonistic effects between antibiotics and biofilm-detaching compounds should be carefully tested in order to achieve an efficient treatment that could prevent both biofilm formation and disruption.

show abstract

Ogilvie′s syndrome following posterior spinal instrumentation in thoraco lumbar trauma

Cited by 10 publications

References 19 publications

Ogilvie syndrome following spinal surgery

Ogilvie syndrome following spinal surgery

Ogilvie's syndrome after paddle spinal cord stimulator implantation: An experience report

Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds

Contact Info

Product

Resources

About